跳至主要内容
临床试验/KCT0006298
KCT0006298
已完成
未知

A 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of unripe Bokbunja Extract on decrease of body fat

Wonkwang University. Iksan Korean Medicine Hospital0 个研究点目标入组 140 人待定

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Endocrine, nutritional and metabolic diseases
发起方
Wonkwang University. Iksan Korean Medicine Hospital
入组人数
140
状态
已完成
最后更新
4年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
2020年12月30日
最后更新
4年前
研究类型
Interventional Study
性别
All

研究者

发起方
Wonkwang University. Iksan Korean Medicine Hospital

入排标准

入选标准

  • 1\) 25 \= BMI \= 34\.9 kg/m2 or 25%(male), 30%(female) \=body fat percentage
  • 2\) Participants who have fully understood information provided about the study, voluntarily decided to participate, and agreed to comply with precautions

排除标准

  • 1\) Participants who have had a weight change of 10% of more within the 3 months prior to the screening examination.
  • 2\) Participants with a clinically significant disease requiring treatment (i.e., acute or chronic cardiovascular system, endocrine system, immune system, respiratory system, kidney and urinary system, neuropsychiatric system, musculoskeletal inflammation, inflammatory disease, blood and tumor disease, gastrointestinal disease, etc.)
  • 3\) Fasteners
  • 4\) Participants with a history of antipsychotic medication use within 3 months prior to the screening examination.
  • 5\) Participants who have participated in other interventional clinical trials within 3 months prior to the screening examination, or plan to participate in other interventional clinical trials.
  • 6\) Participants who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes.

结局指标

主要结局

未指定

相似试验